TARO-TOFACITINIB
TARO PHARMACEUTICALS INC
Quick answers
Is there a shortage of TARO-TOFACITINIB in Canada?
No. There is no current shortage of TARO-TOFACITINIB 5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
XELJANZ
PFIZER CANADA ULC
SANDOZ TOFACITINIB
SANDOZ CANADA INCORPORATED
PMS-TOFACITINIB
PHARMASCIENCE INC
AURO-TOFACITINIB
AURO PHARMA INC
JAMP TOFACITINIB
JAMP PHARMA CORPORATION
Other Products
TARO-TOFACITINIB
TARO PHARMACEUTICALS INC
DIN
02511304
Strength
5MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
TOFACITINIB (TOFACITINIB CITRATE)
See all TOFACITINIB (TOFACITINIB CITRATE) products →Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TARO PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2% · DIN 02247560
DIN 02315033
DIN 02230251
DIN 02304457
0.05% · DIN 00716618
0.1% · DIN 00716626
0.1% · DIN 00716634
0.05% · DIN 00716642
0.1% · DIN 00716650
1% · DIN 00812382
2% · DIN 00812374
1% · DIN 00812366